Pharmaceutical - Xofigo, Regulation, Vaccines

Filter

Current filters:

XofigoRegulationVaccines

UK’s NICE unable to give the go ahead to new prostate cancer drug Xofigo

24-03-2014

The UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has issued new draft…

BayerNorthern EuropeOncologyPharmaceuticalPricingRegulationUKXofigo

EU approval for Bayer’s prostate cancer drug Xofigo

EU approval for Bayer’s prostate cancer drug Xofigo

15-11-2013

The European Commission has granted marketing authorization for German drug and chemical major Bayer’s…

AlgetaBayerEuropeOncologyPharmaceuticalRegulationXofigo

EMA unit backs approval of Bayer's radium-233

EMA unit backs approval of Bayer's radium-233

20-09-2013

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended…

AlgetaBayerEuropeOncologyPharmaceuticalradium-223 dichlorideRegulationXofigo

Fast FDA approval for Bayer's new drug for advanced prostate cancer, Xofigo

16-05-2013

The US Food and Drug Administration yesterday (May 15) approved Xofigo (radium Ra 223 dichloride, initially…

AlgetaAstellas PharmaBayerNorth AmericaOncologyPharmaceuticalRegulationXofigo

Back to top